Penumbra Inc

PEN

Company Profile

  • Business description

    Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

  • Contact

    1310 Harbor Bay Parkway
    One Penumbra Place
    AlamedaCA94502
    USA

    T: +1 510 748-3200

    E: [email protected]

    https://www.penumbrainc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    4,700

Stocks News & Analysis

stocks

ASX listed bank overvalued despite strong earnings

Profit beats drive shares higher for Australia’s largest asset manager.
stocks

After earnings, is Amazon a buy, a sell, or fairly valued?

After the launch of Amazon Supply Chain Services, here’s what we think of the stock.
stocks

ASX retail share expected to recover despite choppy conditions

Weakening consumer demand a temporary headwind for ASX retailer.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,942.4014.500.16%
CAC 408,062.2350.34-0.62%
DAX 4024,300.0238.61-0.16%
Dow JONES (US)49,609.1612.190.02%
FTSE 10010,249.7516.680.16%
HKSE26,394.560.850.00%
NASDAQ26,247.08440.881.71%
Nikkei 22562,417.88295.77-0.47%
NZX 50 Index13,210.4835.350.27%
S&P 5007,398.9361.820.84%
S&P/ASX 2008,701.8011.500.13%
SSE Composite Index4,225.0245.071.08%

Market Movers